Authorized in El Salvador the use of the AstraZeneca vaccine against Covid-19 | El Salvador News

In November, it was announced that Gobierno had a contract with this company for the purchase of 2 million doses of the medicine, but did not specify the amount.

The National Medicines Agency, (DNM) authorizes the importation, distribution and use of the vaccine against Covid-19 of the AstraZeneca company, located in Cambridge, United Kingdom.

According to the communication communicated by the DNM, there is a “special authorization for emergencies” and it was held during an extraordinary session.

You may be interested in: I need to inform you about risks and benefits of vacancies against COVID-19

In addition, the regulatory institution justifies that the pharmacy license is maintained technically and legally in the evidence generated by the manufacturer and by the sanitary authorities of other countries which have issued emergency authorizations for this product.

The most recent official figures of 45 million are 960 confirmed cases with Covid-19; también se mencionan 1 mil 327 muertes.

When it finalizes in November, it is announced that the governor has agreed to buy 2 million doses of the vaccine against covid-19 developed by AstraZeneca and the University of Oxford.

You may be interested in: Medical College: Gobierno agrees with Pfizer to apply for this vacancy in El Salvador

At the moment, the Gobierno has not published any of the stories that involve the purchase of any of these vacancies, and has only announced that its application in the country will not incur any additional costs for the population, and in addition anyone can decide whether to accept or not the injection.

The dudas of the specialists

The AstraZeneca company has to make additional studies to test the function and efficacy of its vaccine against COVID-19, as it appears “impossible that we will have to stay in El Salvador in the first quarter of this year”, Solo esteolologist explains interview with Canal 33.

You may be interested in: Infectologists can help UES to investigate the new variant of COVID-19

Applying to AstraZeneca in the first quarter of 2021 was an announcement by the President of the Republic, Nayib Bukele, in November, even though the mandate explained that it would agree to establish the company that completes the clinical trials.

The specialist Solano Leiva confirms that, as a member of the Assessment Committee for the Practice of Immunization (CAPI), which works together with the Ministry of Health, it is known that the seniors passed the technical visit to Gobierno Salvadoreño Bion que pais, tal como lo había adelantado a El Diario de Hoy el doctor Milton Brizuela, presidente del Colegio Médico.

The retrospective situation in which AstraZeneca went to Gobierno to negotiate with BionTech Pfizer, according to Solano Leiva, states that “it is most likely that we will be in the first quarter of 2021”, as we hope it will be. British-Swedish with what she negotiated.